Alzheimer' disease - will it become a health priority for Europe?

19 January 2011

Every year 1.4 million Europeans develop some type of dementia. It is estimated that 35.6 million people worldwide suffered from dementia in all its forms in 2010. A report debated by European Members of Parliament on Tuesday afternoon called for more sharing of scientific knowledge, raising public awareness to recognize early symptoms and setting up specialist centers.

The number of sufferers of some form of dementia could nearly double every 20 years, possibly reaching 65.7 million in 2030.

The report by Portuguese MEP Marisa Matias (GUE/NGL) calls on European governments to make combating and treating Alzheimer’s disease and other dementias a priority. The report has already been backed by the Parliament's cross party Committee on Environment, Public Health and Food Safety.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical